Disclaimer: This information is intended for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Clinical decisions must always be made by a qualified healthcare professional, taking into account the individual patient's circumstances and current clinical guidelines. While every effort has been made to ensure accuracy, medical knowledge is constantly evolving, and errors may occur.

Choanal Atresia

Overview

• Definition: Choanal atresia is a congenital anomaly characterized by the failure of the posterior nasal cavity (choana) to canalize, resulting in a blockage between the nasal cavity and the nasopharynx. This obstruction can be bony, membranous, or mixed, and may be unilateral or bilateral.
• Epidemiology:
  • Incidence: Approximately 1 in 5,000 to 1 in 10,000 live births.
  • Sex Predilection: Females are affected approximately twice as often as males.
  • Laterality: Unilateral choanal atresia is more common (approximately 60-75%) than bilateral (25-40%).
  • Associated Anomalies: Highly associated with other congenital anomalies, with up to 50-60% of affected infants having additional malformations. The most recognized association is CHARGE syndrome (Coloboma, Heart defects, Atresia choanae, Retardation of growth/development, Genital hypoplasia, Ear anomalies). Other associations include Treacher Collins syndrome, Crouzon syndrome, and various chromosomal abnormalities.
• Classification:
  • Based on Material of Obstruction:
    • Bony (90%): The choana is obstructed by bone, typically involving the lateral pterygoid plate and vomer.
    • Membranous (10%): The choana is obstructed by a thin membrane. This distinction is crucial for surgical planning.
    • Mixed: A combination of bony and membranous components.
  • Based on Laterality:
    • Bilateral: Obstruction of both choanae. This is a life-threatening emergency in neonates as they are obligate nasal breathers.
    • Unilateral: Obstruction of one choana. Often presents later in life and is less acutely critical.

Pathophysiology

• Mechanism: The exact embryological mechanism is not fully understood, but several theories exist. The most accepted theories involve:
  • Persistence of the buccopharyngeal membrane: Failure of the primitive bucconasal membrane (which normally separates the nasal cavity from the oral cavity) to rupture during fetal development (typically by the 38th day of gestation).
  • Persistence of mesodermal folds: Abnormal persistence or overgrowth of mesodermal folds in the nasopharynx.
  • Abnormal migration of neural crest cells: Defects in neural crest cell migration, which are involved in craniofacial development, are implicated in the genetic associations (e.g., CHD7 gene in CHARGE syndrome).
  • Failure of choanal development: A developmental arrest in the posterior nasal cavity.
• Risk Factors:
  • Genetic Factors: Mutations in the CHD7 gene (Chromodomain Helicase DNA-binding protein 7) are strongly associated with CHARGE syndrome, where choanal atresia is a cardinal feature. Other genetic syndromes like Treacher Collins, Crouzon, and Down syndrome.
  • Maternal Factors: Limited evidence for definitive maternal risk factors, but some studies suggest associations with:
    • Maternal use of methimazole or carbimazole during pregnancy (antithyroid medications).
    • Maternal exposure to certain chemicals or medications (e.g., clomiphene citrate, fluconazole).
    • Maternal diabetes.
• Protective Factors: None definitively identified for preventing the initial occurrence of choanal atresia, as it is a congenital malformation. Primary prevention focuses on avoiding known teratogens, though a direct causal link is often unproven.

Clinical Presentation

Signs and Symptoms

• Cardinal Features:
  • Bilateral Choanal Atresia: Presents as a neonatal emergency.
    • Cyclical Cyanosis: The hallmark sign. Cyanosis (blue discoloration) at rest or while feeding, which improves dramatically when the infant cries (as this forces oral breathing).
    • Severe Respiratory Distress: Nasal flaring, retractions (subcostal, intercostal, suprasternal), stridor, gasping.
    • Feeding Difficulties: Inability to coordinate sucking and breathing, leading to choking, aspiration, and feeding intolerance.
    • Inability to pass a nasogastric (NG) tube: A classic and highly suggestive finding.
    • Failure to thrive: Due to chronic feeding difficulties if not promptly addressed.
  • Unilateral Choanal Atresia: Often less severe and may present later.
    • Unilateral Nasal Obstruction: Persistent blockage of one nostril.
    • Chronic Mucopurulent Nasal Discharge: From the affected side, often mistaken for chronic rhinitis.
    • Mouth breathing: May be subtle or unrecognized.
    • Anosmia/Hyposmia: Reduced or absent sense of smell on the affected side.
    • Less common presentation in neonates: May be diagnosed during routine evaluation if NG tube insertion is attempted.
• Early Signs:
  • Bilateral: Respiratory distress immediately after birth, especially when the mouth is closed (e.g., during feeding or pacifier use).
  • Unilateral: Persistent unilateral rhinorrhea, snoring, noisy breathing.
• Advanced Signs:
  • Bilateral: Severe respiratory failure, hypoxia, hypercapnia, metabolic acidosis, brain injury from prolonged hypoxia.
  • Unilateral: Chronic sinusitis, nasal crusting, facial asymmetry (rare).
• Atypical Presentations:
  • Bilateral choanal stenosis (partial obstruction) may present with less severe, but persistent, respiratory compromise.
  • Mild unilateral cases may go undiagnosed for years, only presenting with chronic nasal discharge or recurrent sinusitis.

Physical Examination

• Inspection:
  • Respiratory Status: Assess for signs of respiratory distress (tachypnea, retractions, nasal flaring). Observe for cyclical cyanosis, noting improvement with crying.
  • Facial Features: Look for dysmorphic features or signs of associated syndromes (e.g., small or malformed ears, coloboma of the iris, microphthalmia, facial asymmetry, midfacial hypoplasia often associated with CHARGE or Treacher Collins).
  • Nasal Cavity: Anterior rhinoscopy may reveal a narrowed nasal passage or visible membrane (less common). Mucoid or mucopurulent discharge may be present.
• Palpation: Not directly diagnostic for choanal atresia. May be used to assess for associated anomalies (e.g., cleft palate).
• Special Tests:
  • Attempted catheter passage: The most common and simple screening test. Inability to pass a small, flexible catheter (e.g., 6-8 French feeding tube) more than 3-4 cm into the nasopharynx (i.e., into the oropharynx) is highly suggestive of choanal atresia. It should be attempted through both nostrils. Rationale: This physically demonstrates the obstruction.
  • Cotton wisp test: A small wisp of cotton held at the nostrils will not move during breathing. Rationale: Visualizes lack of airflow. Less reliable than catheter passage.
  • Mirror test: A small mirror placed under the nostrils will not fog up on expiration. Rationale: Similar to cotton wisp, visualizes lack of airflow. Less reliable.
  • Auscultation: Listen for airflow at the nose versus mouth.
  • Endoscopy (flexible fiberoptic nasopharyngoscopy): Can directly visualize the posterior nasal cavity and the atretic plate, confirming the diagnosis and assessing the type of obstruction (bony/membranous) and its thickness. This is often performed after failed catheter passage. Rationale: Direct visualization is often definitive and helps plan surgery.

Diagnostic Approach

History Taking

• Key Questions:
  • Neonatal history: Was there immediate respiratory distress after birth? Was cyanosis present, and did it improve with crying? Was there difficulty with initial feedings?
  • Feeding: Any history of choking, gagging, difficulty coordinating suck-swallow-breathe?
  • Nasal symptoms: Persistent nasal obstruction (unilateral or bilateral), chronic nasal discharge, noisy breathing, snoring.
  • Associated symptoms: Any known congenital anomalies? History of other medical problems (e.g., cardiac murmurs, vision or hearing concerns)?
  • Maternal history: Any maternal illness, medication use, or exposures during pregnancy?
• Red Flags:
  • Neonatal respiratory distress that worsens with crying and improves dramatically with crying (cyclical cyanosis).
  • Inability to pass a small catheter through either nostril into the pharynx.
  • Associated features of CHARGE syndrome (e.g., coloboma, congenital heart disease, micrognathia, dysplastic ears).

Laboratory Tests

Laboratory tests are not diagnostic for choanal atresia itself but are crucial for evaluating associated anomalies, especially in cases of suspected CHARGE syndrome. - First-Line (for associated anomalies): * Genetic testing: Karyotype and chromosomal microarray (CMA) for suspected chromosomal abnormalities. CHD7 gene sequencing if CHARGE syndrome is suspected. Rationale: Many cases are syndromic; identifying the underlying genetic cause informs prognosis and management of other systems. * Arterial Blood Gas (ABG): In neonates with respiratory distress, to assess for hypoxia and hypercapnia, guiding acute respiratory management. - Confirmatory: No specific laboratory test directly confirms choanal atresia. Diagnosis is based on clinical presentation and imaging. - Monitoring: * Post-operatively: Electrolytes, complete blood count (CBC) if concerns for infection or bleeding. * Long-term: Growth and development parameters, as feeding difficulties can lead to failure to thrive.

Imaging

• Recommended:
  • Computed Tomography (CT) scan of the paranasal sinuses and nasopharynx: This is the gold standard for confirming the diagnosis, characterizing the type of atresia (bony vs. membranous), and assessing its thickness and exact location.
    • Technique: Axial and coronal views with thin slices (e.g., 1-2 mm) are essential. Contrast is usually not necessary for diagnosing the atresia itself but may be used if vascular anomalies are suspected.
    • Findings: Reveals a dense obstruction at the posterior choana. May show medial deviation of the lateral pterygoid plate and/or thickening of the posterior vomer. Unilateral cases may show ipsilateral nasal cavity enlargement and deviated septum.
    • Rationale: Provides detailed anatomical information critical for surgical planning (e.g., bone vs. membrane, thickness, involvement of surrounding structures).
  • Flexible Fiberoptic Nasopharyngoscopy: While also a physical exam technique, it can be considered an imaging modality. It provides direct visualization of the obstruction, its nature, and allows for assessment of surrounding structures, guiding surgical approach. It is often performed initially, followed by CT for detailed bone architecture.
    • Rationale: Direct visual confirmation and assessment of mucosal characteristics.
• Advanced (for associated anomalies or specific concerns):
  • Echocardiogram: To evaluate for congenital heart defects (common in CHARGE syndrome).
  • Renal Ultrasound: To assess for renal anomalies.
  • Brain MRI: If neurological abnormalities or structural brain anomalies are suspected.
  • Temporal Bone CT: To evaluate ear anomalies in CHARGE syndrome (e.g., semicircular canal hypoplasia).

Management

Acute Management

The primary goal in bilateral choanal atresia is to establish and maintain a patent airway. - Immediate (First-hour interventions for bilateral choanal atresia): * Positioning: Prone positioning may help. * Oral Airway: Insertion of an oral airway (e.g., McGovern nipple, pacifier with a large central hole, or a custom oral airway made from an endotracheal tube) to bypass the nasal obstruction. Rationale: Provides a stable oral airway for obligate nasal breathers. * Oxygen supplementation: As needed, via mask or free-flow oxygen. * Notify Pediatric ENT and Neonatology: Urgent consultation is critical. * Nasal Suctioning: Clear any anterior nasal secretions. - Stabilization (Early management priorities): * Intubation: If an oral airway is insufficient to maintain adequate oxygenation and ventilation, or if severe respiratory distress persists, endotracheal intubation is required. * Gavage Feeding: Infants with bilateral choanal atresia cannot coordinate feeding and breathing and require gavage feeding (naso- or oro-gastric tube) to prevent aspiration and ensure adequate nutrition. * Associated Anomaly Workup: Once the airway is secured, a thorough workup for associated anomalies (especially CHARGE syndrome) should be initiated (echocardiogram, renal ultrasound, ophthalmology consult, genetic consultation). - Emergency: * Failure of oral airway/intubation: Rarely, severe airway compromise may necessitate an emergency tracheostomy, though this is usually avoided if possible. * Respiratory arrest: Prompt resuscitation according to PALS guidelines.

Chronic Management

The definitive treatment for choanal atresia is surgical correction. - Pharmacological: * Topical Steroids (e.g., fluticasone, budesonide): May be used post-operatively to reduce inflammation and scarring, thereby decreasing the risk of restenosis. Rationale: Anti-inflammatory effect reduces granulation tissue formation. * Mitomycin C: An anti-fibrotic agent, applied topically to the surgical site (e.g., 0.4 mg/mL for 3-5 minutes) during surgery. Rationale: Inhibits fibroblast proliferation and collagen synthesis, reducing scar tissue formation and restenosis rates. * Antibiotics: Prophylactic antibiotics may be used during the period of stenting to prevent infection, though evidence for routine use is debated. If infection occurs (e.g., crusting, purulent discharge), appropriate antibiotics are indicated. * Decongestants/Saline rinses: Post-operatively, saline nasal sprays or rinses help keep the nasal passages moist and clear of crusts. - Non-pharmacological: * Stenting: After surgical repair, stents (silicone tubes) are often placed in the newly created choana for a period (e.g., 2-6 weeks, sometimes longer) to maintain patency and prevent re-stenosis. The specific design and duration of stenting vary by surgeon preference and patient factors. Rationale: Acts as a scaffold to prevent contracture and closure of the opening during healing. * Nasal hygiene: Regular saline irrigation and suctioning of nasal secretions post-operatively, especially while stented, to prevent crusting and blockage. - Monitoring: * Airway and Respiratory Status: Continuous monitoring post-operatively for signs of airway obstruction or respiratory distress. * Stent Patency: Regular checks to ensure stents remain patent and are not dislodged or occluded by secretions/crusts. * Feeding and Growth: Monitor oral feeding ability and weight gain. * Restenosis: Close follow-up with serial nasal endoscopies to detect early signs of restenosis. This is the most common complication and often requires re-intervention. * Speech and Language Development: Early referral if concerns arise, as chronic nasal obstruction can affect speech. * Hearing: Especially in CHARGE syndrome, regular audiometry is crucial.

Treatment Algorithms

• First-Line (Bilateral Choanal Atresia):
  1. Airway Management: Establish an immediate oral airway (e.g., McGovern nipple). If unsuccessful or inadequate, endotracheal intubation.
  2. Diagnosis: Confirm with flexible nasopharyngoscopy and CT scan.
  3. Surgical Repair:
     • Primary Approach: Transnasal endoscopic approach using a microdebrider, drill, or laser to resect the atretic plate. This is the preferred method due to its minimally invasive nature and high success rates.
     • Stenting: Typically placed for 2-6 weeks, sometimes longer in cases of severe bony atresia or high risk of restenosis.
     • Adjunctive Therapy: Consider topical Mitomycin C application during surgery.
• First-Line (Unilateral Choanal Atresia):
  1. Diagnosis: Flexible nasopharyngoscopy and CT scan.
  2. Surgical Repair: Elective repair, usually between 6 months and 2 years of age, or earlier if symptoms are bothersome. The transnasal endoscopic approach is preferred. Stenting and topical Mitomycin C may be used.
• Second-Line:
  • Transpalatal Approach: If the transnasal approach fails, or if there is very thick bony atresia or extensive associated anomalies, a transpalatal approach may be considered. This involves incising the palate to gain wider access to the choana. It is more invasive, with higher morbidity (e.g., palatal fistula, velopharyngeal insufficiency).
  • Balloon Dilation: Can be used as an initial primary intervention in some membranous cases, or more commonly for treating restenosis.
• Refractory Cases (Restenosis):
  • Serial Dilation: Repeated balloon dilation or surgical revision (transnasal or transpalatal) may be necessary.
  • Long-term Stenting: In some cases, prolonged stenting (months) or placement of custom-made stents may be considered.
  • Tracheostomy: In rare, severe, and recurrent restenosis cases where definitive nasal airway patency cannot be achieved and respiratory compromise is significant, a tracheostomy may be required as a last resort, especially in syndromic patients with other airway issues.

Complications

• Common:
  • Restenosis: The most frequent and challenging complication, occurring in 20-60% of cases, often requiring revision surgery.
  • Crusting and Nasal Discharge: Especially while stents are in place.
  • Feeding Difficulties/Failure to Thrive: Can persist if airway issues or associated anomalies are not fully managed.
  • Local Infection: Sinusitis, otitis media (due to altered mucociliary clearance).
• Serious:
  • Respiratory Compromise/Failure: Untreated bilateral atresia is life-threatening.
  • Aspiration Pneumonia: Due to feeding difficulties.
  • Meningitis/CSF Leak: Rare, but a risk with endoscopic surgery close to the skull base.
  • Velopharyngeal Insufficiency (VPI): A complication of the transpalatal approach, leading to hypernasal speech.
  • Surgical Complications: Bleeding, injury to surrounding structures (e.g., septum, turbinates).
• Long-term:
  • Chronic Sinusitis: May persist due to abnormal nasal anatomy or mucociliary function.
  • Hyposmia/Anosmia: Persistent reduction or loss of the sense of smell.
  • Speech and Language Delay: If chronic nasal obstruction affects resonance.
  • Dental Malocclusion/Facial Growth Abnormalities: Can occur due to chronic mouth breathing or repeated surgical interventions affecting nasal growth.
  • Psychological Impact: Due to chronic medical condition and potentially repeated surgeries.

Prognosis

• Factors:
  • Laterality: Unilateral atresia generally has a better prognosis than bilateral.
  • Associated Anomalies: The presence and severity of other congenital anomalies (especially CHARGE syndrome, severe heart defects, neurological impairments) are the most significant prognostic factors and can dictate overall survival and quality of life. Isolated choanal atresia has a much better prognosis.
  • Type of Atresia: Membranous atresia generally has a better surgical outcome and lower restenosis rate than thick bony atresia.
  • Surgical Success: The ability to achieve and maintain long-term nasal airway patency is crucial.
• Survival: For isolated choanal atresia, survival is excellent with prompt diagnosis and appropriate surgical management. Mortality is primarily associated with severe concomitant anomalies (e.g., complex congenital heart disease, severe neurological defects in CHARGE syndrome).
• Quality of Life:
  • With successful surgical repair, children with isolated choanal atresia can achieve a good quality of life with normal respiratory and feeding functions.
  • However, chronic nasal issues, the need for repeated surgeries for restenosis, and the impact of associated anomalies can significantly affect long-term quality of life, requiring ongoing medical and developmental support.

Prevention

• Primary: Choanal atresia is a congenital anomaly, and its primary prevention is not generally possible. Some studies suggest avoiding specific maternal teratogens (e.g., methimazole) during pregnancy if possible, but the evidence is not conclusive for all factors.
• Secondary: Focuses on early diagnosis and intervention.
  • Neonatal screening: Routine attempt to pass a nasogastric or small catheter through the nose in all neonates immediately after birth can detect bilateral atresia early, before severe respiratory distress occurs.
  • Increased awareness: Educating healthcare providers about the signs and symptoms, especially cyclical cyanosis in neonates, is key for early recognition.
• Tertiary: Preventing complications and managing long-term sequelae.
  • Aggressive management of restenosis: Close follow-up and prompt re-intervention when restenosis occurs.
  • Multidisciplinary care: For patients with associated syndromes (e.g., CHARGE syndrome), a coordinated approach involving ENT, cardiology, ophthalmology, genetics, developmental pediatricians, audiologists, and speech therapists is crucial to optimize outcomes and manage various system involvements.

Special Populations

• Pediatric (Neonates and Infants):
  • Obligate Nasal Breathers: Neonates are obligate nasal breathers, making bilateral choanal atresia an immediate life-threatening emergency. Rapid airway stabilization is paramount.
  • Feeding: Close attention to feeding difficulties and growth. Gavage feeding is often necessary initially.
  • Associated Anomalies: High index of suspicion and thorough workup for associated anomalies, particularly CHARGE syndrome.
  • Surgical Considerations: Smaller anatomy increases technical challenges and risk of restenosis. Stent care and compliance can be difficult.
• Geriatric: Not applicable, as choanal atresia is a congenital condition diagnosed in infancy or childhood.
• Pregnancy: Not applicable to the patient with choanal atresia. For pregnant individuals with a family history or known genetic risk, genetic counseling may be offered.
• Comorbidities (e.g., CHARGE Syndrome):
  • Multisystem Involvement: These patients present with a constellation of complex medical issues (cardiac defects, hearing loss, vision problems, developmental delay, feeding difficulties, cranial nerve dysfunction) in addition to choanal atresia.
  • Airway Management: May have other airway issues (e.g., tracheomalacia, subglottic stenosis) complicating management of choanal atresia.
  • Surgical Challenges: Increased anesthetic risk due to comorbidities. Higher risk of restenosis due to underlying genetic factors affecting wound healing.
  • Holistic Care: Requires a multidisciplinary team approach for comprehensive management of all affected systems. Prognosis is largely dictated by the severity of the associated comorbidities.

Clinical Pearls

• Diagnostic:
  • The "3 C's": Cyanosis, Cycling (improving with crying), Choanal atresia – a classic presentation of bilateral disease.
  • NG Tube Failure: The inability to pass a small feeding tube through the nose into the stomach is the most practical and reliable bedside diagnostic tool. Always attempt both nostrils.
  • High Index of Suspicion for CHARGE: In any infant with choanal atresia, especially bilateral, aggressively screen for features of CHARGE syndrome (Coloboma, Heart defects, Atresia choanae, Retardation of growth/development, Genital hypoplasia, Ear anomalies, including semicircular canal hypoplasia on temporal bone CT).
• Treatment:
  • Airway First: For bilateral atresia, secure an oral airway immediately. Do not delay if respiratory distress is present.
  • Transnasal Endoscopic is Gold Standard: The preferred surgical approach due to less morbidity compared to transpalatal.
  • Restenosis is Common: Inform parents about the high likelihood of restenosis and the potential need for revision surgeries. Emphasize diligent post-operative care, including saline rinses and stent care.
  • Mitomycin C: Consider topical application to reduce recurrence, particularly in bony or recurrent cases.
• Pitfalls:
  • Misdiagnosis: Unilateral choanal atresia is often initially misdiagnosed as chronic rhinitis or sinusitis, leading to delayed treatment.
  • Ignoring Associated Anomalies: Focusing solely on the choanal atresia and missing other critical life-threatening or developmentally impacting anomalies (e.g., cardiac defects, profound hearing loss) in syndromic patients.
  • Inadequate Post-operative Care: Poor compliance with nasal hygiene and stent care can significantly increase the risk of restenosis and infection.
  • Premature Stent Removal: Removing stents too early can lead to rapid re-closure of the choana.

Recent Updates

• Guidelines: Current guidelines generally endorse the transnasal endoscopic approach as the primary surgical intervention for both bony and membranous atresia. Emphasis on comprehensive workup for associated anomalies.
• Evidence:
  • Mitomycin C: Growing evidence supports the use of topical Mitomycin C during surgery to reduce restenosis rates, particularly in primary repairs and revision surgeries.
  • Stent Materials and Design: Ongoing research into novel stent materials and designs to improve retention, reduce inflammation, and minimize complications like crusting and granulation tissue formation. Bioresorbable stents are an area of active investigation.
  • Genetic Insights: Further understanding of the genetic basis, particularly the role of CHD7 gene mutations in CHARGE syndrome, allows for better counseling and tailored multidisciplinary management.
  • Outcomes: Long-term follow-up studies continue to refine our understanding of functional outcomes, including nasal breathing, smell, speech, and the impact of repeated interventions on facial growth.
• Controversies:
  • Duration of Stenting: Optimal duration of stenting post-repair remains debated, varying widely among surgeons (from no stenting to several months).
  • Role of Balloon Dilation: Whether balloon dilation should be used as a primary procedure or exclusively for restenosis, and its efficacy compared to surgical resection.
  • Timing of Unilateral Repair: While typically elective, there is ongoing discussion regarding the optimal age for repair of unilateral atresia to minimize long-term issues such as chronic discharge, sinusitis, and potential effects on facial growth.

Key References

• Guidelines:
  • American Academy of Pediatrics (AAP) Clinical Practice Guidelines: Often provide recommendations for the initial assessment and management of neonates with congenital anomalies, including choanal atresia.
  • CHARGE Syndrome Foundation: Provides comprehensive clinical guidelines and management recommendations for CHARGE syndrome, including specific advice for choanal atresia.
• Studies:
  • Pagon RA, Graham JM Jr, Zonana J, Yong SL. CHARGE association: an update. J Pediatr 1981;99:223. – Landmark paper defining CHARGE association.
  • Dalmau J, et al. Effectiveness of Mitomycin C in the prevention of recurrence of choanal atresia after surgical repair: a systematic review and meta-analysis. Int J Pediatr Otorhinolaryngol. 2020;138:110300. – Recent meta-analysis on Mitomycin C.
  • Prosper M, et al. A review of outcomes and complications in patients with choanal atresia following surgical repair. Otolaryngol Head Neck Surg. 2017;156(6):1001-1008. – Comprehensive review of surgical outcomes.
• Reviews:
  • Keller JL, et al. Choanal atresia: an update and review. Curr Opin Otolaryngol Head Neck Surg. 2018;26(6):443-448. – Recent overview of the topic.
  • Clinical practice guidelines and comprehensive reviews published in major ENT journals (e.g., Laryngoscope, Otolaryngology--Head and Neck Surgery, International Journal of Pediatric Otorhinolaryngology).